Thrivent Financial for Lutherans
MLAB icon

Thrivent Financial for Lutherans’s Mesa Laboratories MLAB Stock Holding History

Thrivent Financial for Lutherans’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,996
Closed -$377K – 2529
2025
Q2 		$377K Buy
3,996
+5
+0.1% +$549 ﹤0.01% 2244
2025
Q1 		$474K Sell
3,991
-207
-5% -$28.2K ﹤0.01% 2097
2024
Q4 		$554K Sell
4,198
-50
-1% -$6.14K ﹤0.01% 2219
2024
Q3 		$552K Sell
4,248
-6
-0.1% -$706 ﹤0.01% 2215
2024
Q2 		$369K Sell
4,254
-191
-4% -$20K ﹤0.01% 2328
2024
Q1 		$488K Sell
4,445
-119
-3% -$12K ﹤0.01% 2249
2023
Q4 		$478K Sell
4,564
-115
-2% -$11.2K ﹤0.01% 2220
2023
Q3 		$492K Sell
4,679
-128
-3% -$16.4K ﹤0.01% 2143
2023
Q2 		$618K Sell
4,807
-173
-3% -$26.4K ﹤0.01% 2094
2023
Q1 		$870K Sell
4,980
-166
-3% -$29.7K ﹤0.01% 1863
2022
Q4 		$855K Sell
5,146
-20
-0.4% -$3.13K ﹤0.01% 1826
2022
Q3 		$728K Sell
5,166
-8
-0.2% -$1.46K ﹤0.01% 1875
2022
Q2 		$1.05M Buy
5,174
+903
+21% +$198K ﹤0.01% 1683
2022
Q1 		$1.09M Buy
4,271
+19
+0.4% +$5.16K ﹤0.01% 1775
2021
Q4 		$1.4M Buy
4,252
+46
+1% +$14.4K ﹤0.01% 1641
2021
Q3 		$1.27M Buy
4,206
+213
+5% +$60.5K ﹤0.01% 1675
2021
Q2 		$1.08M Sell
3,993
-12
-0.3% -$3.04K ﹤0.01% 1787
2021
Q1 		$975K Sell
4,005
-27,337
-87% -$7.52M ﹤0.01% 1887
2020
Q4 		$8.98M Buy
31,342
+323
+1% +$88.9K 0.02% 680
2020
Q3 		$7.9M Sell
31,019
-135
-0.4% -$32.1K 0.02% 665
2020
Q2 		$6.75M Buy
31,154
+189
+0.6% +$43.6K 0.02% 646
2020
Q1 		$7M Buy
30,965
+1,483
+5% +$366K 0.03% 581
2019
Q4 		$7.35M Buy
29,482
+26,299
+826% +$6.16M 0.02% 645
2019
Q3 		$757K Sell
3,183
-5,838
-65% -$1.35M ﹤0.01% 1595
2019
Q2 		$2.2M Buy
+9,021
New +$2.1M 0.01% 944

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Thrivent Financial for Lutherans's MLAB Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 3,996 shares — an estimated $377K sold.

Thrivent Financial for Lutherans first reported a position in MLAB in Q2 2019 and held it in 25 quarters. The position peaked at $8.98M in Q4 2020. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 3,996 Mesa Laboratories shares in Q3 2025, an estimated $377K.
  • Thrivent Financial for Lutherans first reported a position in Mesa Laboratories in Q2 2019 and held it in 25 quarters.
  • Thrivent Financial for Lutherans's Mesa Laboratories position peaked at $8.98M in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.